SinoMab BioScience Ltd
8 clinical trials · Sponsor
◉ Watch SinoMab BioScience Ltd
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Evaluate SM17 for Atopic Dermatitis (NCT07445919) | SinoMab BioScience Ltd | 2026-03-31 |
| A Clinical Study to Evaluate SM17 in Healthy Participants (NCT07466940) | SinoMab BioScience Ltd | 2025-10-14 |
| A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis (NCT07103369) | SinoMab BioScience Ltd | 2023-11-21 |
| A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects (NCT05332834) | SinoMab BioScience Ltd | 2022-06-14 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject (NCT04041544) | SinoMab BioScience Ltd | 2019-08-27 |
| A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX (NCT04312815) | SinoMab BioScience Ltd | 2017-12-28 |
Track SinoMab BioScience Ltd automatically
Every clearance here is in the API, with alerts when new ones post.